OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Reduced binding and neutralization of infection- and vaccine-induced antibodies to the B.1.351 (South African) SARS-CoV-2 variant
Venkata Viswanadh Edara, Carson Norwood, Katharine Floyd, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 42
Venkata Viswanadh Edara, Carson Norwood, Katharine Floyd, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 42
Showing 26-50 of 42 citing articles:
Superior cellular and humoral immunity toward SARS-CoV-2 reference and alpha and beta VOC strains in COVID-19 convalescent as compared to the prime boost BNT162b2-vaccinated dialysis patients
Arturo Blázquez-Navarro, Lema Safi, Toni Luise Meister, et al.
Kidney International (2021) Vol. 100, Iss. 3, pp. 698-700
Open Access | Times Cited: 9
Arturo Blázquez-Navarro, Lema Safi, Toni Luise Meister, et al.
Kidney International (2021) Vol. 100, Iss. 3, pp. 698-700
Open Access | Times Cited: 9
Neutralization Heterogeneity of Circulating SARS-CoV-2 Variants to Sera Elicited by a Vaccinee or Convalescent
Meng Zhang, Yixin Gong, Shunchang Jiao
Future Virology (2022) Vol. 17, Iss. 6, pp. 403-413
Open Access | Times Cited: 6
Meng Zhang, Yixin Gong, Shunchang Jiao
Future Virology (2022) Vol. 17, Iss. 6, pp. 403-413
Open Access | Times Cited: 6
Coronaviruses
Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2021) Vol. 31, Iss. 4, pp. 291-294
Closed Access | Times Cited: 8
Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2021) Vol. 31, Iss. 4, pp. 291-294
Closed Access | Times Cited: 8
Passive Immunity Should and Will Work for COVID-19 for Some Patients
Nevio Cimolai
Clinical Hematology International (2021) Vol. 3, Iss. 2, pp. 47-47
Open Access | Times Cited: 5
Nevio Cimolai
Clinical Hematology International (2021) Vol. 3, Iss. 2, pp. 47-47
Open Access | Times Cited: 5
A Reverse Transcription Recombinase-Aided Amplification Method for Rapid and Point-of-Care Detection of SARS-CoV-2, including Variants
Fengyun Li, Ping He, Dongyan Xiong, et al.
Viruses (2021) Vol. 13, Iss. 9, pp. 1875-1875
Open Access | Times Cited: 5
Fengyun Li, Ping He, Dongyan Xiong, et al.
Viruses (2021) Vol. 13, Iss. 9, pp. 1875-1875
Open Access | Times Cited: 5
A Combination Adjuvant for the Induction of Potent Antiviral Immune Responses for a Recombinant SARS-CoV-2 Protein Vaccine
Sonia Jangra, Jeffrey J. Landers, Raveen Rathnasinghe, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
Sonia Jangra, Jeffrey J. Landers, Raveen Rathnasinghe, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
Impacto de las variantes genéticas de la espícula en las vacunas frente al SARS-CoV-2
Jordi Reina, Pablo A. Fraile-Ribot
Vacunas (2021) Vol. 22, Iss. 2, pp. 59-61
Open Access | Times Cited: 4
Jordi Reina, Pablo A. Fraile-Ribot
Vacunas (2021) Vol. 22, Iss. 2, pp. 59-61
Open Access | Times Cited: 4
Development of highly potent neutralising nanobodies against multiple SARS-CoV-2 variants including the variant of concern B.1.351
Agnieszka M. Sziemel, Shi-Hsia Hwa, Alex Sigal, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 3
Agnieszka M. Sziemel, Shi-Hsia Hwa, Alex Sigal, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 3
Ending transmission of SARS-CoV-2: sterilizing immunity using an intranasal subunit vaccine
Ankita Leekha, Arash Saeedi, Samiur Rahman Sefat, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Ankita Leekha, Arash Saeedi, Samiur Rahman Sefat, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Structures of synthetic nanobody–SARS-CoV-2–RBD complexes reveal distinct sites of interaction and recognition of variants
David H. Margulies, Javeed Ahmad, Jiansheng Jiang, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 1
David H. Margulies, Javeed Ahmad, Jiansheng Jiang, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 1
The effect of RNA and non-RNA vaccines in variants of Covid-19: A narrative review
Maryam Rahmannia, Shahryar Rajai Firouzabadi, Ahad Hasan Syed Hasani, et al.
(2021) Vol. 15, Iss. 7, pp. 2112-2122
Open Access | Times Cited: 1
Maryam Rahmannia, Shahryar Rajai Firouzabadi, Ahad Hasan Syed Hasani, et al.
(2021) Vol. 15, Iss. 7, pp. 2112-2122
Open Access | Times Cited: 1
An intranasally administrated SARS-CoV-2 beta variant subunit booster vaccine prevents beta variant viral replication in rhesus macaques
Yongjun Sui, Jianping Li, Hanné Andersen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Yongjun Sui, Jianping Li, Hanné Andersen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Broad human and animal coronavirus neutralisation by SARS-CoV-2 S2-targeted vaccination
Kevin W. Ng, Nikhil Faulkner, Katja Finsterbusch, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 1
Kevin W. Ng, Nikhil Faulkner, Katja Finsterbusch, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 1
A COVID-19 megelőzésére szolgáló vakcinák összetétele, működési elve
Gábor Deli, Ágnes Pataki, Blanka Emődy-Kiss, et al.
Honvédorvos (2020) Vol. 72, Iss. 3-4, pp. 7-25
Open Access
Gábor Deli, Ágnes Pataki, Blanka Emődy-Kiss, et al.
Honvédorvos (2020) Vol. 72, Iss. 3-4, pp. 7-25
Open Access
'Geno-to-pheno' SARS-CoV-2 genome-COVID-19 association studies
Julian W. Tang
EBioMedicine (2021) Vol. 66, pp. 103333-103333
Open Access
Julian W. Tang
EBioMedicine (2021) Vol. 66, pp. 103333-103333
Open Access
SARS-CoV-2 Therapeutic Landscape, Opportunity and Future Threats
O. P. Sharma, Werner Seiz, Juergen Scheele
The Open COVID Journal (2021) Vol. 1, Iss. 1, pp. 205-215
Open Access
O. P. Sharma, Werner Seiz, Juergen Scheele
The Open COVID Journal (2021) Vol. 1, Iss. 1, pp. 205-215
Open Access
Impact of spike genetic variants in vaccines against SARS-CoV-2
Jordi Reina, Pablo A. Fraile-Ribot
Vacunas (English Edition) (2021) Vol. 22, Iss. 2, pp. 59-61
Closed Access
Jordi Reina, Pablo A. Fraile-Ribot
Vacunas (English Edition) (2021) Vol. 22, Iss. 2, pp. 59-61
Closed Access
